Ph.D., Rice University, 2004
political economy, African studies, science and medicine, Nigeria and West Africa, postcolonial theory, Black political thought; pharmaceuticals, markets, theories of capital, intellectual property law, clinical research, AIDS, security studies, NGOs and humanitarianism, feminism, ethnographic methods
SBSG 3336 | 949-824-9652
My research and writing are concerned with theories of capital and property; “popular” economies, trade, and markets; health, science, and medicine studies; and postcolonial theory. I am especially interested in bringing medical anthropology and science and technology studies in conversation with African Studies and postcolonial iterations of political economy.
My first book, Speculative Markets: Drug Circuits and Derivative Life in Nigeria (Duke University Press, 2014), describes a once thriving brand name pharmaceutical market in Nigeria that transformed into one of the world’s worst fake (and inefficacious) drug problems. Drawing on the stories and lives of industry executives, pharmaceutical market traders, industry and academic pharmacists, drug marketers, narcotics traders, and regulatory officials, I describe the making of drug chemistries and market dynamics in the aftermath of 1980s liberalization. I particularly focus on the intertwined nature of pharmaceutical industry speculation and speculative practices found in Nigerian drug markets. Both must anticipate immense market volatility while managing new risks and chronic uncertainty. In tying market actors to both local and transcontinental economic strategies, the book resituates how we think about market making and non-equilibrium theories of neoliberalism in the postcolony and beyond.
With Morenike O. Folayan (Obafemi Awolowo University), a book manuscript, The Trials and Tribulations of Clinical Research in Africa, is in-progress. Our focus is on pre-exposure prophylaxis (PrEP) HIV prevention technologies that were designed and funded by U.S. federal government programs, international HIV prevention research consortiums, and international social marketing firms. We examine African debates on ethics and clinical research that interface with market logics and extensive trial failure